BioRem Inc.
BRM.VTSXVIndustrials● Active
$3.08
+$0.04(+1.32%)
Market Cap$49948357
P/E Ratio—
52W High$3.57
52W Low$1.84
BioRem Inc. (BRM.V) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · BRM.V · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $42.36M | $37.42M | $25.17M | $28.86M | $24.48M |
| Cost of Revenue | $29.77M | $27.36M | $18.14M | $20.10M | $18.24M |
| Gross Profit | $12.59M | $10.06M | $7.02M | $8.76M | $6.24M |
| Gross Margin %(computed) | 29.72% | 26.87% | 27.90% | 30.36% | 25.48% |
| Operating Expenses | |||||
| R&D Expenses | $0.05M | $0.04M | $0.03M | $0.10M | $0.01M |
| G&A Expenses | $0.00M | $2.12M | $1.63M | $3.20M | $1.82M |
| Total Operating Expenses | $6.01M | $5.71M | $3.96M | $5.88M | $3.90M |
| Operating Income | $6.57M | $4.34M | $3.06M | $2.64M | $2.07M |
| Operating Margin %(computed) | 15.52% | 11.61% | 12.17% | 9.15% | 8.46% |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.16M | $0.20M | $0.27M | $0.26M | $0.04M |
| Income Before Tax | $6.33M | $4.15M | $2.79M | $2.38M | $2.03M |
| Income Tax Expense | $1.51M | $1.10M | $0.61M | $0.77M | $0.74M |
| Net Income | $4.82M | $3.04M | $2.18M | $1.61M | $1.30M |
| Net Margin %(computed) | 11.37% | 8.13% | 8.66% | 5.59% | 5.30% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.30 | $0.19 | $0.14 | $0.10 | $0.04 |
| Wtd Avg Shares | 16.03M | 15.76M | 15.67M | 15.48M | 35.92M |
| EBITDA | $7.05M | $4.82M | $3.45M | $2.99M | $2.68M |
| EBITDA Margin %(computed) | 16.63% | 12.87% | 13.69% | 10.36% | 10.94% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · CAD · M
Explore more BioRem Inc. data
About BioRem Inc. (BRM.V) Income Statement
BioRem Inc. (BRM.V) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, BRM.V reported revenue of $0.04B, gross profit of $0.01B (gross margin 29.72%), and net income of $0.00B — a net profit margin of 11.37%.
Frequently asked questions
BRM.V · 4 questionsBioRem Inc. (BRM.V) reported revenue of $0.04B for 2025, up 13.2% year-over-year.
BRM.V revenueBRM.V salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08